• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Monarch Medical Technologies appoints diabetes tech veteran as new CEO

August 7, 2020 By Sean Whooley

Monarch Medical Technologies announced that it appointed industry veteran Raymie McFarland as its new president & CEO.

As McFarland takes over day-to-day management, Brian Duffy and Christophe Mallard, two of the Charlotte, N.C.-based diabetes technology company’s board members, will relinquish their respective roles as interim CEO and interim president.

McFarland spent the previous nine years with Glytec, having most recently served as the company’s chief innovation & outcomes officer. Before Glytec, McFarland worked at Sanofi in diabetes care.

“We are thrilled to welcome Raymie to the Monarch family,” Duffy said in a news release. “He is, as many people will attest, a one-of-a-kind talent. His in-depth knowledge of diabetes and, more specifically, of glycemic management and insulin therapies, is extraordinary.”

“Raymie’s track record of success in cultivating customer relationships, building high-performing teams, engaging key opinion leaders and generating revenue is unimpeachable,” Mallard added. “He has a keen ability to articulate the benefits of innovative tools, technologies and processes to clinicians, administrators and senior executives alike. He is also highly experienced in conducting scientific research and measuring both clinical efficacy and financial ROI.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations Tagged With: Monarch Medical Technologies, Personnel Moves

IN CASE YOU MISSED IT

  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling
  • Senseonics stock is up as it sticks by revenue guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS